echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > CSH Innovation Forum| Ji Chunyan, Li Jian, Qian Wenbin, Liu Peng, Li Xin invite you to join the academic feast on September 23-25 - the 17th National Hematology Academic Conference of the Chinese Medical Association

    CSH Innovation Forum| Ji Chunyan, Li Jian, Qian Wenbin, Liu Peng, Li Xin invite you to join the academic feast on September 23-25 - the 17th National Hematology Academic Conference of the Chinese Medical Association

    • Last Update: 2022-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Listening to the sound of blood and perceiving the rhythm of life, the much-anticipated "17th National Hematology Academic Conference of the Chinese Medical Association" will be grandly opened
    on September 23-25, 2022 at the National Convention and Exhibition Center in Shanghai.




    Precision diagnosis and treatment frontier forum


    September 23 13:30-16:30


    Professor Ji Chunyan

    Qilu Hospital, Shandong University


    In recent years, with the rapid development of bioinformatics technology, artificial intelligence technology, and life science disciplines, the concept of "precision diagnosis and treatment" has gradually attracted attention
    .



    The conference invited Professor Wu Shiyong, Director of the Statistical Information Center of the National Health Commission and Executive Vice President of the China Society for Health Information and Health and Medical Big Data, Professor He Xuhua of Duke University Medical Center, Professor Biying Chang of the Blood Disease Hospital of the Chinese Academy of Medical Sciences and many other well-known experts at home and abroad to conduct academic exchanges on
    the "Precision Diagnosis and Treatment of Blood System Diseases".



    Rare Diseases Forum

    September 23 13:30-17:00


    Professor Li Jian

    Peking Union Medical College Hospital


    Hello everyone, as the chairman of the Rare Disease Forum at the Innovation Venue of the Conference, I would like to welcome everyone to participate in the Rare Disease Forum
    .



    Cell Therapy MDT Forum

    September 23 13:30-18:00


    Professor Qian Wenbin

    The Second Affiliated Hospital of Zhejiang University School of Medicine


    Dear experts and colleagues, welcome to the Cell Therapy MDT Forum
    .
    The first CAR-T therapeutic product has been approved for marketing in China
    .
    Unlike conventional immunochemotherapy, the associated toxicity of CAR-T therapy requires multidisciplinary management, including cytokine release syndrome and associated neurotoxicity
    .
    The conference is very honored to invite five well-known MDT teams in China, namely the MDT team of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the MDT team of West China Hospital of Sichuan University, the MDT team of Chinese People's Liberation Army General Hospital, the MDT team of Zhujiang Hospital of Southern Medical University, and the MDT team of the Second Affiliated Hospital of Zhejiang University School of Medicine, which will bring wonderful content
    to everyone.


    CLL China-Foreign Exchange Session

    September 23 13:30-17:15


    Professor Liu Peng

    Zhongshan Hospital Affiliated to Fudan University


    Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in Europe and the United States, and there are more and more
    patients with CLL in China.
    With the deepening of the understanding of the disease and the continuous updating of treatment methods, the diagnosis and treatment of CLL has made rapid progress
    .
    Small molecule drugs include BTK inhibitors, PI3K inhibitors and other small molecule inhibitors, antibodies and cellular immunotherapy and other means emerge in an endless stream
    .
    I hope that this exchange session can bring new harvests to everyone and promote the further development of CLL diagnosis and treatment!


    Innovation Forum on Immunodeficiency and Infection

    September 9 23:13-30:16


    Professor Li Xin

    The Third Xiangya Hospital of Central South University


    The importance of immunodeficiency and infection treatment for patients with blood diseases is self-evident, so this forum invites heavyweight experts in many disciplines such as blood diseases, respiratory diseases, infectious diseases and basic research to answer the confusion faced in practical clinical diagnosis and treatment, and also brings innovative clinical and scientific research ideas
    。 The forum featured six unique topics covering a comprehensive range of topics: pathologically covering fungi, bacteria and viruses; Diagnostic means cover the accurate diagnosis of inflammatory indicators and NGS; Lung infections with the highest incidence will be highlighted on the type of infection; At the same time, experts in the field of basic scientific research shared new ideas
    on basic research and clinical translation.
    I believe that through the study and exchange of this forum, greater innovation and progress will be made in the field of immunodeficiency and infection!



    September 23-25

    The 17th National Conference on Hematology of the Chinese Medical Association

    Respect, heritage, collaboration, innovation

    Welcome to Shanghai!


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.